Results:

(English) ESG News Review 1 — 7 March 2014

10 03 2014

Désolé, cet article est seulement disponible en Anglais Américain.


L’indice 60 atteint +25% depuis janvier

26 11 2013

Nestlé a tiré son épingle du jeu dans l’actualité Environnement, Social, Gouvernance (ESG) du mois d’octobre, grà¢ce notamment au 2013 Creating Shared Value Forum, qui a mis en évidence les efforts de la société en matière de développement rural en Amérique latine, et son engagement à  construire de nouvelles écoles en Côte d’Ivoire dans le […]


(English) ESG News Review 12 — 18 October 2013

21 10 2013

Désolé, cet article est seulement disponible en Anglais Américain.


Pharma Reputations: Managing Perceptions

14 08 2012

Geneva-based Covalence, a company that markets the information system, EthicalQuote, has observed that pharma is not keeping pace with other industries in terms of the overall balance of global good and bad news coverage in four broad ethical areas: labour standards, waste management, product social utility and human rights policy. “The pharma industry is losing […]


Appel à  clarifier les prélà¨vements d’organes sur des prisonniers en Chine

16 08 2010

Amnesty International Suisse veut un code de conduite pour les entreprises actives dans la transplantation d’organes en Chine, un pays qui utilise des condamnés à  mort. Novartis répond favorablement. Roche se tait. Ils seront plus de 4000 experts à  participer dès dimanche à  Vancouver au 23e congrès interna­tional de la Société de transplantation: médecins, chirurgiens, […]


Pharmas Challenged by Product Risk and Philanthropy Fatigue – Covalence Pharmaceutical Industry Report 2008

9 09 2008

Increased attention on product human risk and smaller media coverage of drug donations have challenged Pharmaceuticals’ ethical reputation last year, states a report published today by Geneva-based research firm Covalence — Covalence Pharmaceutical Industry Report 2008. The pharmaceutical industry dropped from the first to the third rank of Covalence all-time EthicalQuote ranking across 10 industries. […]


Index sur l’Accà¨s aux Médicaments : Publication des résultats

25 06 2008

L’accès aux médicaments dans les pays en voie de développement est un des grands défis posé actuellement aux entreprises pharmaceutiques. Conscients du problème, Ethos et plusieurs investisseurs institutionnels soutiennent le projet « Index sur l’Accès aux Médicaments ». Cette initiative internationale a pour but de mesurer et de comparer l’approche des différentes entreprises pharmaceutiques en […]


The Burden of Innovation – Covalence Pharmaceutical Industry Report 2007

29 08 2007

Pharmaceutical companies carry increasing ethical risks related to innovation, states a report released on 29 August 2007 by Geneva-based ethical reputation research firm Covalence, Covalence Pharmaceutical Industry Report 2007. These innovation-related risks deal with intellectual property rights, drug pricing, clinical trials, drug side-effects and transparency. In terms of ethical reputation, innovation seems to bring more […]


Big Pharma’s new Africa plan

5 07 2007

Unless delegates to a high-profile summit on diabetes in Kenya last week knew it had been paid for by the world’s biggest maker of insulin, they would have been none the wiser when they left. The conference, in the lush surroundings of a four-star hotel outside Nairobi and attended by ministers from three African governments, […]


The Ethically Challenged: How Pharma Fares

31 05 2007

In these ethically challenging times, which drugmaker has its act together? Covalence, a research group based in Geneva that tracks ethical reputations, recently released its quarterly update in which various industrial sectors were examined. The firm compiles its rankings and charts by collecting reports – both positive and negative recent news – from the Internet […]